NCT06396065Phase 3Active not recruiting

Phase III Study of AK112 for NSCLC Patients

Study sponsor: Summit Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-04-12Actual
Enrollment · participants420Actual
Source updated2026-07-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 31 Dec 2025. After: 12 Apr 2025.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview